![Maureen Deehan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Maureen Deehan
Director Ejecutivo en Vivtex Corp. .
Cargos activos de Maureen Deehan
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Vivtex Corp. | Director Ejecutivo | 21/02/2023 | - |
Director de Operaciones | 01/12/2022 | 21/02/2023 |
Historial de carrera de Maureen Deehan
Antiguos cargos conocidos de Maureen Deehan.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
THOR MEDICAL | Corporate Officer/Principal | 01/06/2018 | - |
Formación de Maureen Deehan.
University of Glasgow School of Medicine | Doctorate Degree |
University of Strathclyde | Undergraduate Degree |
Estadísticas
Internacional
Reino Unido | 3 |
Noruega | 2 |
Estados Unidos | 2 |
Operativa
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorial
Consumer Services | 3 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Nordic Nanovector ASA
![]() Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Vivtex Corp. |
- Bolsa de valores
- Insiders
- Maureen Deehan
- Experiencia